PDFLARGE FONT PDF

Gallium Citrate Ga 67 Injection, USP

Gallium Citrate Ga 67


Consumer Medicine Information

What is in this leaflet

This leaflet answers some of the common questions about Gallium Citrate Ga 67. It does not contain all of the available information about Gallium Citrate Ga 67. It does not replace talking to your doctor.

All medicines have risks and benefits. Your doctor has weighed the risks of you receiving Gallium Citrate Ga 67 against the benefits he or she expects it will have.

If you have any concerns about having this medicine, ask your doctor.

Keep this leaflet. You may need to read it again.

What is Gallium Citrate Ga 67

Gallium Citrate Ga 67 Injection contains an isotope of the element Gallium and belongs to a group of medicines called radiopharmaceutical agents, which are all radioactive.

What Gallium Citrate Ga 67 is used for

Gallium Citrate Ga 67 is used to demonstrate the presence of following malignancies: Hodgkins disease, lymphomas and bronchogenic carcinoma. Positive Ga 67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state.

Your doctor may have prescribed Gallium Citrate Ga 67 for another purpose. Ask your doctor if you have any questions about why Gallium Citrate Ga 67 has been prescribed for you. If you have any concerns, you should discuss these with your doctor.

This medicine is only available with a doctor’s prescription.

Before you are given Gallium Citrate Ga 67

Before you are given Gallium Citrate Ga 67 your doctor will explain to you the procedure you are about to undergo, and the radioactive medicine you will be given. You must discuss any concerns you have with your doctor.

Gallium Citrate Ga 67 is not recommended for patients less than 18 years of age. If your doctor believes it is necessary to give Gallium Citrate Ga 67 to a patient under 18, he or she will discuss the benefits and risks with you.

You must tell your doctor if you have allergies to:

  • any other medicines
  • any other substances such as foods, preservatives or dyes

Tell your doctor if you are or plan to become pregnant. Like most medicines Gallium Citrate Ga 67 is not recommended for use during pregnancy. If there is a need to consider Gallium Citrate Ga 67 during your pregnancy, your doctor will discuss the benefits and risks of giving it to you. If you are given Gallium Citrate Ga 67 when you are pregnant, your developing baby will be exposed to the radiation.

Tell your doctor if you are breastfeeding or plan to breastfeed. Like most medicines Gallium Citrate Ga 67 is not recommended while you are breastfeeding. However if you are breastfeeding, formula feedings should be substituted for breastfeeding for 24 hours following the administration of Gallium Citrate Ga 67. Breast milk produced within that time should be discarded.

Tell your doctor if you have any other medical conditions, especially if you suffer from heart disease or from diabetes.

Taking other medicines

Tell your doctor if you are taking any other medicines, including medicines that you buy without a prescription from pharmacy, supermarket or health food shop.

How Gallium Citrate Ga 67 is given

How much is given

Your doctor will decide how much you will be given.

You will receive Gallium Citrate Ga 67 as a single intravenous one injection. The uptake of Ga 67 may be measured form a period of 6 hours up to 72 hours after administration of the dose.

How it is given

Gallium Citrate Ga 67 is given as an injection into a vein. Gallium Citrate Ga 67 should only be given by a doctor or a nurse.

When you are given Gallium Citrate Ga 67

Things you must do

You must take daily laxatives and/or enemas during the first week after the procedure. This will remove as much radioactivity as possible from your bowel and minimise the possibility of false positive studies.

Things you must not do

Do not take any other medicines until advised by your doctor.

Things to be careful of

Do not drive or operate machinery until you know how Gallium Citrate Ga 67 affects you. Gallium Citrate Ga 67 may cause dizziness in some people. Make sure you know how you react to Gallium Citrate Ga 67 before you drive a car, operate machinery or do anything else that could be dangerous if you are dizzy.

Side effects

Tell your doctor as soon as possible if you do not feel well after being given Gallium Citrate Ga 67.

Tell your doctor or a nurse immediately if you notice any of the following:

  • dizziness
  • light-headedness
  • itchiness
  • rash

Product description

What it looks like

Gallium Citrate Ga 67 is a clear solution supplied in vials. An injection is prepared from the vial immediately before it is injected.

Ingredients

Active ingredient:
Gallium Citrate Ga 67.

Inactive Ingredients:

  • sodium citrate,
  • sodium chloride,
  • benzyl alcohol.

Sponsor

Lantheus MI Australia Pty Ltd
Unit 8/24-26 Carrick Drive
Tullamarine
Victoria 3043

Registration Number

AUST R 19144

Date of Preparation

Updated: April 2012

Gallium Citrate(cmi)2.doc

Published by MIMS January 2015

Consumers should be aware that the information provided by the Consumer Medicines Information (CMI) search (CMI Search) is for information purposes only and consumers should continue to obtain professional advice from a qualified healthcare professional regarding any condition for which they have searched for CMI. CMIs are provided by MIMS Australia. CMI is supplied by the relevant pharmaceutical company for each consumer medical product. All copyright and responsibility for CMI is that of the relevant pharmaceutical company. MIMS Australia uses its best endeavours to ensure that at the time of publishing, as indicated on the publishing date for each resource (e.g. Published by MIMS/myDr January 2007), the CMI provided was complete to the best of MIMS Australia's knowledge. The CMI and the CMI Search are not intended to be used by consumers to diagnose, treat, cure or prevent any disease or for any therapeutic purpose. Dr Me Pty Limited, its servants and agents shall not be responsible for the continued currency of the CMI, or for any errors, omissions or inaccuracies in the CMI and/or the CMI Search whether arising from negligence or otherwise or from any other consequence arising there from.